Your browser doesn't support javascript.
loading
Erratum to "Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease." Kidney Int. 2023;104:787-802.
Lizotte, Farah; Rousseau, Marina; Denhez, Benoit; Lévesque, Dominique; Guay, Andréanne; Liu, HongBo; Moreau, Julie; Higgins, Sarah; Sabbagh, Robert; Susztak, Katalin; Boisvert, François-Michel; Côté, Anne Marie; Geraldes, Pedro.
Afiliação
  • Lizotte F; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Rousseau M; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Denhez B; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Lévesque D; Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Guay A; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Liu H; Renal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Penn/CHOP Kidney Innovation Center, University of Pennsylvania, Philadelphia, Penn
  • Moreau J; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Higgins S; Division of Nephrology, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Sabbagh R; Department of Surgery, Université de Sherbrooke, Québec, Canada.
  • Susztak K; Renal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Penn/CHOP Kidney Innovation Center, University of Pennsylvania, Philadelphia, Penn
  • Boisvert FM; Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Côté AM; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada; Division of Nephrology, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Geraldes P; Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada; Division of Endocrinology, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: Pedro.Geraldes@USherbrooke.ca.
Kidney Int ; 104(6): 1228, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37981434
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article